Institutional investors purchased a net $1.6 million shares of MEIP during the quarter ended March 2014 and now own 64.82% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LMR PARTNERS LLP Bought 26.1 Thousand shares of MEI Pharma Inc